/
/
En omfattande förfarande för att utvärdera<em> In Vivo</em> Prestanda av cancer nano
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Chapters
- 00:05Title
- 00:56Synthesis of Dual-labeled Liposomal Nanoparticles
- 03:22In Vivo PET-CT Imaging and Ex Vivo Biodistribution Measurements
- 06:19Results: Biodistribution of Fluorescent- and Radiolabeled Nanoparticles in Tumor-bearing Mice
- 07:14Conclusion
The poor understanding of the in vivo performance of nanomedicines stymies their clinical translation. Procedures to evaluate the in vivo behavior of cancer nanomedicines at systemic, tissue, single-cell, and subcellular levels in tumor-bearing immunocompetent mice are described here. This approach may help researchers to identify promising cancer nanomedicines for clinical translation.
